tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Cardiex Limited’s Entitlement Offer Closing Soon

Story Highlights
Cardiex Limited’s Entitlement Offer Closing Soon

Elevate Your Investing Strategy:

CardieX ( (AU:CDX) ) just unveiled an announcement.

Cardiex Limited has announced the closing of its Entitlement Offer, set for 5:00 pm AEST on 20 June 2025. This offer allows eligible shareholders to purchase new shares at $0.04 each, matching the price of a recent Institutional Placement. The initiative is part of Cardiex’s efforts to bolster its financial standing and support its mission to innovate in the field of vascular health. This move is expected to enhance shareholder value and strengthen the company’s market position.

More about CardieX

Cardiex is a company focused on advancing medical technology for vascular health, with products including medical and home health devices, as well as digital solutions for conditions like hypertension and cardiovascular disease. Their offerings are based on the SphygmoCor® vascular biomarker technology, and the company is listed on the Australian Stock Exchange under the ticker ASX: CDX.

Average Trading Volume: 300,084

Technical Sentiment Signal: Sell

Current Market Cap: A$21.45M

See more insights into CDX stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1